LIBMELDY FUNDAMENTALS EXPLAINED

The pill formulation of zanubrutinib (Brukinsa; BeOne) is now approved for all 5 indications throughout many hematological cancers.To make Libmeldy, the CD34+ cells (cells which can make white blood cells) are extracted within the blood or bone marrow. A gene allowing for them to generate ARSA is inserted into the CD34+ cells using a style of virus